Adverse effect
hideIn medicine, an adverse effect is a harmful and undesired effect resulting from a medication or other intervention such as surgery. An adverse effect may be termed a "side effect", when judged to be secondary to a main or therapeutic effect, and may result from an unsuitable or incorrect dosage or procedure, which could be due to medical error. Adverse effects are sometimes referred to as "iatrogenic" because they are generated by a physician/treatment. Some adverse effects only occur only when starting, increasing or discontinuing a treatment. Using a drug or other medical intervention which is contraindicated may increase the risk of adverse effects. Adverse effects may cause medical complications of a disease or procedure and negatively affect its prognosis. They may also lead to non-compliance with a treatment regimen.
The harmful outcome is usually indicated by some result such as morbidity, mortality, alteration in body weight, levels of enzymes, loss of function, or as a pathological change detected at the microscopic, macroscopic or physiological level. It may also be indicated by symptoms reported by a patient. Adverse effects may cause a reversible or irreversible change, including an increase or decrease in the susceptibility of the individual to other chemicals, foods, or procedures, such as drug interactions.
In clinical trials, a distinction is made between adverse events (AEs) and serious adverse events (SAEs). Generally, any event which causes death, permanent damage, birth defects, or requires hospitalization is considered an SAE. The results of these trials are often included in the labeling of the medication to provide information both for patients and the prescribing physicians.
For more information about Adverse effect, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with side effects
Study confirms that cannabis is beneficial for multiple sclerosis
Medicine & Health / Neuroscience
Dec 04, 2009 |
5 / 5 (20) |
0
Cannabis can reduce spasticity in multiple sclerosis (MS) patients. A systematic review, published in the open access journal BMC Neurology, found that five out six randomized controlled trials reported a reduction in spa ...
Drug shows positive responses, low side-effects in multiple myeloma
Dec 07, 2009 |
not rated yet |
0
NEW ORLEANS ― The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers ...
Study points to new uses, unexpected side effects of already existing drugs
Nov 04, 2009 |
5 / 5 (3) |
0
Scientists at the University of North Carolina at Chapel Hill School of Medicine and the University of California, San Francisco have developed and experimentally tested a technique to predict new target diseases ...
GAO: FDA yet to make safety changes post-Vioxx
Medicine & Health / Medications
Dec 09, 2009 |
not rated yet |
0
(AP) -- The Food and Drug Administration still hasn't restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal.
Second-line CML drugs evoke faster response than front-line therapy
Dec 07, 2009 |
not rated yet |
0
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University ...
New mechanisms of action found for drugs used to treat anxiety disorders
Jun 23, 2009 |
4 / 5 (5) |
0
(PhysOrg.com) -- In the course of his or her life, every seventh German will develop an anxiety disorder that will require treatment. Standard anti-anxiety medications (anxiolytics) are based on the benzodiazepine ...
Licorice compound offers new cancer prevention strategy
Mar 23, 2009 |
4.7 / 5 (3) |
1
A chemical component of licorice may offer a new approach to preventing colorectal cancer without the adverse side effects of other preventive therapies, Vanderbilt University Medical Center researchers report.
Grapefruit juice boosts drug's anti-cancer effects
Apr 20, 2009 |
4.6 / 5 (7) |
1
In a small, early clinical trial, researchers at the University of Chicago Medical Center have found that combining eight ounces of grapefruit juice with the drug rapamycin can increase drug levels, allowing lower doses of ...
Researchers Isolate Protein Domain Linked to Tumor Progression
Feb 17, 2009 |
4.5 / 5 (2) |
0
(PhysOrg.com) -- When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. The drug inhibited a family of enzymes known as matrix ...
What causes motor complications of Parkinson's treatment?
Jan 29, 2009 |
not rated yet |
0
People with Parkinson's disease commonly suffer a slowing or freezing of movement caused by the death of neurons that make dopamine, a key chemical that allows brain cells to send and receive messages essential ...
Scientists unravel structure of key breast cancer target enzyme
Jan 07, 2009 |
5 / 5 (2) |
0
The molecular details of Aromatase, the key enzyme required for the body to make estrogen, are no longer a mystery thanks to the structural biology work done by the Ghosh lab at the Hauptman-Woodward Medical ...
Side effects not always due to swine flu shot
Oct 31, 2009 |
not rated yet |
1
(AP) -- Hundreds of people on any given day will die, develop the paralyzing Guillain-Barre syndrome or have spontaneous abortions, and that doesn't necessarily mean that their swine flu vaccination shot was to blame, a ...
Long-term testicular cancer survivors at high risk for neurological side effects
Nov 25, 2009 |
not rated yet |
0
Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with ...
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
Nov 05, 2009 |
3 / 5 (1) |
0
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat ...
New platinum-phosphate compounds kill ovarian cancer cells
Nov 19, 2008 |
3.8 / 5 (4) |
0
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the ...
